Strata Skin Scien (SSKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,983 | -2,835 | -5,549 | -5,389 | -4,394 |
| Depreciation Amortization | 3,076 | 1,543 | 5,845 | 4,335 | 2,917 |
| Income taxes - deferred | N/A | N/A | 40 | N/A | N/A |
| Accounts receivable | 208 | 626 | -1,145 | -246 | 491 |
| Other Working Capital | 1,565 | 245 | -2,885 | -1,400 | 260 |
| Other Operating Activity | 1,264 | -396 | 2,770 | 1,597 | 317 |
| Operating Cash Flow | $130 | $-817 | $-924 | $-1,103 | $-409 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,495 | -1,792 | -3,736 | -2,037 | -1,510 |
| Net Acquisitions | N/A | N/A | -631 | -631 | -631 |
| Investing Cash Flow | $-3,495 | $-1,792 | $-4,367 | $-2,668 | $-2,141 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -35 | 0 | -500 | 0 | 0 |
| Financing Cash Flow | $6,965 | $N/A | $-500 | $N/A | $N/A |
| Beginning Cash Position | 6,795 | 6,795 | 12,586 | 12,586 | 12,586 |
| End Cash Position | 10,395 | 4,186 | 6,795 | 8,815 | 10,036 |
| Net Cash Flow | $3,600 | $-2,609 | $-5,791 | $-3,771 | $-2,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | 130 | -817 | -924 | -1,103 | -409 |
| Capital Expenditure | -3,495 | -1,792 | -3,736 | -2,037 | -1,510 |
| Free Cash Flow | -3,365 | -2,609 | -4,660 | -3,140 | -1,919 |